Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
69 auth. J. Frater, K. Ewer, A. Ogbe, M. Pace, S. Adele, E. Adland, J. Alagaratnam, P. Aley, Mohammad Ali, M. Ansari, A. Bara, M. Bittaye, S. Broadhead, A. Brown, Helen L. Brown, ... F. Cappuccini, E. Cooney, W. Dejnirattisai, C. Dold, C. Fairhead, H. Fok, P. Folegatti, J. Fowler, C. Gibbs, A. Goodman, D. Jenkin, Mathew Jones, R. Makinson, Natalie Marchevsky, Y. Mujadidi, H. Nguyen, L. Parolini, C. Petersen, Emma L Plested, K. Pollock, M. Ramasamy, S. Rhead, H. Robinson, N. Robinson, P. Rongkard, F. Ryan, Sonia Serrano, Timothy Tipoe, M. Voysey, A. Waters, P. Zacharopoulou, E. Barnes, S. Dunachie, P. Goulder, P. Klenerman, G. Screaton, A. Winston, A. Hill, S. Gilbert, A. Pollard, S. Fidler, J. Fox, T. Lambe, Marion E. E. Watson, R. Song, P. Cicconi, A. Minassian, S. Bibi, S. Kerridge, Nisha Singh, Catherine M. Green, Alexander D. Douglas, A. Lawrie, E. Clutterbuck